Skip to main content
. 2018 Jan 8;9(4):667–673. doi: 10.7150/jca.22119

Table 1.

miRNAs targeting the mTOR pathway and cancers

miRNA Target gene Cancer Function Reference
miR-7 AKT liver cancer proliferation, invasion 37
miR-22 mTOR suprarenal epithelioma metastasis 21
miR-99 mTOR melanoma tumor formation 38
miR-99a mTOR cervical carcinoma, pancreatic cancer, esophageal squamous cell carcinoma, breast cancer proliferation, invasion, apoptosis 39, 40
miR-99b mTOR pancreatic cancer proliferation, apoptosis 41
miR-100 mTOR bladder cancer, oophoroma,
liver cancer
proliferation, cell cycle, autophagy, tumor formation 42
miR-101 EZH2 liver cancer proliferation, invasion, cell cycle, 43
miR-125a mTOR liver cancer metastasis 31
miR-125b mTOR sarcoma,
small cell osteosarcoma
proliferation, metastasis, cell cycle, apoptosis 44, 45
miR-149 mTOR liver cancer proliferation 46
miR-193a-3p/5p mTOR NSCLC proliferation, migration, epithelial mesenchymal transition (EMT) 47
miR-199a mTOR gliocytoma, endometrial cancer,
liver cancer
proliferation 17
miR-204 mTOR NSCLC, oophoroma metastasis 48
miR-634 mTOR cervical carcinoma proliferation, metastasis, apoptosis 49
miR-21 TSC gastric cancer, lymphadenoma proliferation, cell cycle 50
miR-1271 mTOR gastric cancer proliferation, apoptosis 51
miR-96 mTOR prostatic cancer proliferation, metastasis 52
miR-155 AKT cervical cancer autophagy 53
miR-205 PTEN NSCLC proliferation, angiogenesis 18
miR-451 mTOR colon cancer proliferation, migration 23
miR-532-5p mTOR gastric cancer proliferation, metastasis 54